Vera Therapeutics (VERA)

• Market cap: $2.99B
• 1 day: -4.36%
• 5 days: -3.01%
• 1 month: -5.98%
• 3 months: 47.64%
• 6 months: 90.98%
• Year to date: -13.31%
• 1 year: 42.78%
• 5 years: 266.52%
• 10 years: 266.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Employees: 224